These results, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 aid the concept of focusing on ACKR3 as a unique technique to modulate the opioid procedure, which could open new therapeutic avenues for opioid-relevant Conditions. “Overall, the invention from the https://henryj369vsn0.yomoblog.com/profile